Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Zhonghua Wai Ke Za Zhi ; 60(2): 140-147, 2022 Feb 01.
Article in Chinese | MEDLINE | ID: mdl-35012273

ABSTRACT

Objective: To compare the short-term efficacy and long-term prognosis of laparoscopic and laparotomy radical resection for gallbladder cancer(GBC). Methods: From January 2010 to December 2020,the clinical data and survival information for 133 patients who underwent radical resection of GBC at the Department of Hepatopancreatobiliary Surgery,Zhejiang Provincial People's Hospital,were retrospectively collected. Eighty patients(23 males and 57 females) underwent laparoscopic radical resection and had a median age(M(IQR)) of 66.0(12.8)years(range:28.0 to 82.0 years). Fifty-three patients(45 males and 8 females) who received laparotomy were 63.0(6.0)years old(range:45.0 to 80.0 years old). There were no significant differences in age,gender,body mass index,preoperative albumin,preoperative total bilirubin,N stages,vascular invasion,peri-neural invasion or tumor differentiation between the laparoscopic and laparotomy group(all P>0.05). But there were significant differences in preoperative CA19-9(Z=-2.955, P=0.003), preoperative ALT level(Z=-2.801,P=0.031) and T stage (χ2=19.110,P=0.007) between the two groups. A non-parametric test was used for quantitative data. χ2 test or Fisher exact probability method was used for count data. Results: Patients in the laparoscopic group did not differ from those in the laparotomy group in terms of length of operation,number of lymph node yield,number of positive lymph nodes,the incidence of intraoperative gallbladder rupture,incidence of postoperative bile leakage,abdominal bleeding or abdominal infection,30-day mortality,90-day mortality, the incidence of incision implantation or peritoneal cavity metastasis(all P>0.05). Patients in the laparoscopic group showed less intraoperative bleeding(100.0(200.0)ml vs. 400.0(250.0)ml)(Z=-5.260,P<0.01),fewer days with drainage tube indwelling(6.0(3.8)days vs. 7.0(4.0)days)(Z=-3.351, P=0.001), and fewer postoperative days in hospital(8.0(5.0)days vs. 14.0(7.5)days)(Z=-6.079,P<0.01) than those in the laparotomy group. Patients in the laparoscopic group displayed better overall survival (P<0.01) and progression-free survival (P<0.01). Subgroup analysis for GBC of T1b-T2 and T3 stages revealed comparable overall survival and progression-free survival between the laparoscopic and laparotomy groups (P>0.05). Conclusions: Laparoscopic radical resection can achieve long-term survival for GBC comparable to that with open surgery. Laparoscopic radical resection has advantages over open surgery regarding surgical trauma and postoperative recovery.


Subject(s)
Gallbladder Neoplasms , Laparoscopy , Aged , Aged, 80 and over , Child , Female , Gallbladder Neoplasms/surgery , Humans , Laparotomy , Male , Middle Aged , Prognosis , Retrospective Studies , Treatment Outcome
2.
Genet Mol Res ; 15(3)2016 Aug 26.
Article in English | MEDLINE | ID: mdl-27706619

ABSTRACT

In this study, we assessed the association between the EFEMP1 rs3791679 polymorphism and glioma risk in a Chinese Han population. A total of 94 glioma patients and 206 healthy controls who conformed to the inclusion and exclusion criteria were recruited from Baogang Hospital between March 2012 and October 2014. The EFEMP1 rs3791679 gene polymorphism was assessed using a polymerase chain reaction-restriction fragment length polymorphism assay and the results were statistically analyzed using SPSS Statistics 17.0. The results of unconditional logistic regression analysis revealed that the GG genotype of EFEMP1 rs3791679 was positively correlated with increased susceptibility to glioma (adjusted OR = 2.09, 95%CI = 1.21-7.81). Moreover, the GG genotype of EFEMP1 rs3791679 was correlated with higher risk of glioma compared to the AA+GA genotype (OR = 2.60, 95%CI = 1.08-6.28) in the regressive model. In conclusion, we report that the EFEMP1 rs3791679 polymorphism influences glioma susceptibility in the Chinese Han population.


Subject(s)
Brain Neoplasms/genetics , Extracellular Matrix Proteins/genetics , Genetic Predisposition to Disease , Glioma/genetics , Polymorphism, Single Nucleotide , Adult , Asian People , Brain Neoplasms/diagnosis , Brain Neoplasms/ethnology , Brain Neoplasms/pathology , Case-Control Studies , Female , Gene Expression , Glioma/diagnosis , Glioma/ethnology , Glioma/pathology , Humans , Logistic Models , Male , Middle Aged , Models, Genetic , Odds Ratio , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Risk Factors
3.
J Int Med Res ; 39(5): 1701-12, 2011.
Article in English | MEDLINE | ID: mdl-22117970

ABSTRACT

Inhibition of survivin by small interfering RNA (siRNA) can delay glioma growth. To enhance the effect of survivin-siRNA on intercranial glioma, a conjugate of siRNA-survivin and single-chain variable fragment (scFv) of the transferrin receptor (TfR) was constructed and its effects assessed in vitro and in vivo. SurvivinsiRNA and the survivin-siRNA/scFv-TfR conjugate were constructed and used successfully to inhibit glioma U87 cell proliferation and enhance apoptosis in vitro. The molecular constructs were administered to an established U87 orthotopic mouse model. Western blot analysis and immunohistochemistry of the glioma tissues showed that survivin protein levels were strongly suppressed by the survivin-siRNA/scFv-TfR conjugate in vivo. Furthermore, survivin-siRNA/scFv-TfR prolonged the survival time of mice more than survivin-siRNA. In conclusion, the survivin-siRNA/scFv-TfR conjugate efficiently enhanced the effects of survivin-siRNA on glioma suppression in vivo, confirming the applicability of antibody-targeted molecular therapies for treating human brain tumours.


Subject(s)
Brain Neoplasms/drug therapy , Glioma/drug therapy , Inhibitor of Apoptosis Proteins/genetics , RNA, Small Interfering/pharmacology , Receptors, Transferrin/metabolism , Single-Chain Antibodies/pharmacology , Animals , Apoptosis , Brain Neoplasms/metabolism , Cell Line, Tumor , Cell Proliferation , Female , Gene Expression , Gene Knockdown Techniques , Glioma/metabolism , Humans , Inhibitor of Apoptosis Proteins/metabolism , Kaplan-Meier Estimate , Mice , Mice, Nude , Molecular Targeted Therapy , RNA, Small Interfering/therapeutic use , Single-Chain Antibodies/therapeutic use , Survivin , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL
...